News
A Major Advance in Pancreatic Cancer Care
A new drug called daraxonrasib nearly doubled survival rates for patients... Here goes the content ...
Dr. Sylvia Daunert has been named a Fellow of the National Academy of Inventors, recognizing a career marked by innovations and discoveries aimed at improving patient care. University of Miami researchers report that biomarkers and MRI show similar performance in predicting prostate cancer risk. Combining blood biomarkers with cognitive testing improves prediction of functional decline in people at risk for Alzheimer’s disease. Researchers at the Diabetes Research Institute are using engineering-based models to investigate how lymph node environments may drive type 1 diabetes.
National Academy of Inventors Names Miller School of Medicine’s Dr. Sylvia Daunert Fellow for Lifetime of Innovation
Five Radiation Treatments Match 26 for Localized Prostate Cancer, Miami HEAT Trial Finds
Blood Biomarkers and Cognitive Testing Improve Prediction of Early Alzheimer’s Decline
Engineering New Clues to Type 1 Diabetes at the Diabetes Research Institute
